Lui, Justin K. http://orcid.org/0000-0002-4745-3766
Sangani, Ruchika A.
Gillmeyer, Kari R.
Vakhshoorzadeh, Jasmine
Trojanowski, Marcin A.
Bujor, Andreea M.
Gopal, Deepa M.
Wiener, Renda Soylemez
LaValley, Michael P.
Klings, Elizabeth S.
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (1F32HL156614-01, 1R01HL155955-01A1, 1UG3 HL143192-01A1)
United Therapeutics Corporation
Parker B. Francis Fellowship
American Heart Association (FTF17FTF33670369)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (CCCR P30 AR072571)
National Center for Advancing Translational Sciences (2UL1TR001430-05A1)
Health Resources and Services Administration (U1EMC27864‐08‐00)
Bayer
Forma Therapeutics
Novartis
Article History
Accepted: 26 December 2022
First Online: 6 January 2023
Change Date: 20 January 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s10557-023-07431-6
Declarations
:
: This was retrospective, single-center, observational study of patients with systemic sclerosis enrolled into the Scleroderma Biorepository at Boston University Chobanian & Avedisian School of Medicine. At the time of enrollment, patients were consented for inclusion in this longitudinal clinical registry. The study was approved by the Boston University Medical Campus and Boston Medical Center Institutional Review Board.
: The authors affirm that the study participants provided informed consent for publication of results in a medical book or journal.
: J. K. L. received research support from United Therapeutics. E. S. K. received royalties for 3 topic cards in UpToDate. She is a consultant/advisory board member for Bluebird Bio, FORMA Therapeutics, Vertex, and CSL Behring for sickle cell disease-related clinical trials (no conflict with the present work). All other authors declare no financial interests.
: The views presented here do not necessarily reflect the views of the Department of Veterans Affairs or the US government.